Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Inclusion Criteria:
Exclusion Criteria:
Ghent, 9000, Belgium
Etobicoke, M9C 5N2, Canada
České Budějovice, 37087, Czechia
Ostrava-Poruba, 70852, Czechia
Berlin, 12200, Germany
Mannheim, 68159, Germany
Regensburg, 93053, Germany
Schwerin, 19053, Germany
Gwangju, 61469, South Korea
Seoul, 5030, South Korea